Results 101 to 110 of about 97,918 (260)

Goldberger sign and fragmented QRS in severe left ventricular dysfunction

Cardiologia Hungarica
The authors present the co-occurrence of the Goldberger ECG triad and fragmented QRS in patient with acute decompensated heart failure, severe left ventricular dysfunction and non-compact cardiomyopathy.
János Tomcsányi, Péter Arányi, Kristóf Tomcsányi, Pál Kiss   +3 more
doaj  

All that Doesn’t Enhance Isn’t a Thrombus: Pitfalls Using Cardiac MRI TI 600 Sequence to Distinguish Between Cardiac Thrombus Versus Myxoma

Methodist DeBakey Cardiovascular Journal
A 51-year-old male with a complicated medical history presented with shortness of breath. Preoperative workup confirmed the presence of a large atrial mass.
Aakash D. Rana, Srikanth Vallurupalli, Mark Mitchell, David Duncan, Jack Xu   +4 more
doaj   +1 more source

Optimized High Temperature PEM Fuel Cell & High Pressure PEM Electrolyser for Regenerative Fuel Cell Systems in GEO Telecommunication Satellites

E3S Web of Conferences, 2017
Next generation telecommunication satellites will demand increasingly more power. Power levels up to 50 kW are foreseen for the next decades. Battery technology that can sustain up to 50 kW for eclipse lengths of up to 72 minutes will represent a major ...
Farnes Jarle, Bokach Dmitry, ten Hoopen Sander, Skåtun Kim, Schautz Max, Geneste Xavier, Vik Arild   +6 more
doaj   +1 more source

CARDIOVASCULAR MAGNETIC RESONANCE ADVANCED IMAGING TECHNIQUES IN COMPETITIVE ATHLETES

, 2023
reservedBBACKGROUND: Cardiovascular Magnetic Resonance is the primary imaging modality for the non-invasive myocardial tissue characterization, and it is considered as the gold standard technique for quantifying cardiac function, myocardial volumes and ...
CAILOTTO, ALESSANDRO
core  

Fetal CMR for prenatal interventions

, 2020
Fetal CMR for prenatal interventionsPresented at SCMR 2020 : Interventional CMR Course : Session 4 : New ...
Joshua van Amerom (1422274)
core   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

Comparison of Cardiac Activated Fibroblast Imaging and Magnetic Resonance Imaging in Patients with COVID-19-Related Myocarditis

Reviews in Cardiovascular Medicine
Background: This study aimed to explore the association between cardiac fibroblast activation and cardiac magnetic resonance (CMR) imaging parameters in patients with myocarditis following infection with coronavirus 2019 (COVID-19).
Yao Su, Xin Liu, Boqia Xie, Bowen Zhang, Qi Yang, Min-Fu Yang   +5 more
doaj   +1 more source

sj-pdf-2-cmr-10.1177_00081256241242166 – Supplemental material for Closing the Innovation Performance Gap: Open Innovation in Military Bureaucracies

Supplemental material, sj-pdf-2-cmr-10.1177_00081256241242166 for Closing the Innovation Performance Gap: Open Innovation in Military Bureaucracies by Jasper Heeren, Vareska van de Vrande, Henk Volberda and Erik de Waard in California Management ...
Erik de Waard (18435929), Henk Volberda (7199402), Jasper Heeren (18435926), Vareska van de Vrande (11892335)   +3 more
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source